<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Impact of Atmospheric Pollutants on the Prevalence of Atopic Eczema in 6-7-Year-Old Schoolchildren in Spain; ISAAC Phase III</title>
    <FirstPage>220</FirstPage>
    <LastPage>227</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mar&#xED;a Morales</FirstName>
        <LastName>Su&#xE1;rez-Varela</LastName>
        <affiliation locale="en_US">Unit of Public Health, Hygiene, and Environmental Care, Department of Preventive Medicine, University of Valencia, Valencia, Spain AND CIBER Epidemiology and Public Health (CIBERESP), Spain AND Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Amparo</FirstName>
        <LastName>Gallardo-Juan</LastName>
        <affiliation locale="en_US">Section of Radiology, General Hospital, Valencia. Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Lu&#xED;s</FirstName>
        <LastName>Garc&#xED;a-Marcos</LastName>
        <affiliation locale="en_US">Pediatric Respiratory Medicine and Allergy Units, 'Virgen de la Arrixaca' University Children's Hospital, University of Murcia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Natalia</FirstName>
        <LastName>Gimeno-Clemente</LastName>
        <affiliation locale="en_US">Unit of Public Health, Hygiene, and Environmental Care, Department of Preventive Medicine, University of Valencia, Valencia, Spain AND CIBER Epidemiology and Public Health (CIBERESP), Spain AND Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Angel L&#xF3;pez</FirstName>
        <LastName>Silvarrey-Varela</LastName>
        <affiliation locale="en_US">Foundation Mar&#xED;a Jos&#xE9; Jove, A Coru&#xF1;a, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>I&#xF1;aqui</FirstName>
        <LastName>Miner-Canflanca</LastName>
        <affiliation locale="en_US">Department of Paediatrics, Hospital de Donostia, San Sebasti&#xE1;n, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Jos&#xE9;</FirstName>
        <LastName>Batlles-Garrido</LastName>
        <affiliation locale="en_US">Department of Paediatrics, Hospital Torrec&#xE1;rdenas, Almer&#xED;a, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Alfredo</FirstName>
        <LastName>Blanco-Quiros</LastName>
        <affiliation locale="en_US">Department of Paediatrics, University of Valladolid, Valladolid, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Rosa Mar&#xED;a</FirstName>
        <LastName>Busquets-Monge</LastName>
        <affiliation locale="en_US">Department of Paediatrics, Hospital del Mar, Barcelona, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Bego&#xF1;a</FirstName>
        <LastName>Dom&#xED;nguez-Aurrecoechea</LastName>
        <affiliation locale="en_US">Health Centre of Otero, Oviedo, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Alberto</FirstName>
        <LastName>Arnedo-Pena</LastName>
        <affiliation locale="en_US">Section of Epidemiology, Centre of Public Health, Regional Ministry of Health, Castell&#xF3;n, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Carlos</FirstName>
        <LastName>Gonz&#xE1;lez-D&#xED;az</LastName>
        <affiliation locale="en_US">Unit of Paediatric Allergy, Department of Paediatrics, Hospital of Basurto, Bilbao, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>In&#xE9;s</FirstName>
        <LastName>Aguinaga-Ontoso</LastName>
        <affiliation locale="en_US">Department of Health Sciences, Public University of Navarra, Navarra, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Antonio</FirstName>
        <LastName>Mart&#xED;nez-Gimeno</LastName>
        <affiliation locale="en_US">Department of Pediatrics, "Santa Luc&#xED;a" University Hospital, Cartagena, Spain</affiliation>
      </Author>
      <Author>
        <FirstName>Agust&#xED;n</FirstName>
        <LastName>Llopis-Gonz&#xE1;lez</LastName>
        <affiliation locale="en_US">Unit of Public Health, Hygiene, and Environmental Care, Department of Preventive Medicine, University of Valencia, Valencia, Spain AND CIBER Epidemiology and Public Health (CIBERESP), Spain AND Center for Public Health Research (CSISP), Valencia, Spain</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Atopic Eczema (AE) is a chronic inflammatory skin disease that affects children and adults, and alters quality of life with a high morbidity rate and severe economic burden. The objective of the present work was to analyse specific atmospheric pollutants (O3, NO, PM10 and SO2) affecting the prevalence of diagnosed AE and its symptoms among 6-7-year-old schoolchildren.
The participants included 21311 schoolchildren aged 6-7 years from 8 Spanish regions, whose parents completed the ISAAC Phase III questionnaire to ascertain AE diagnosis and symptoms. The mean levels (&#xB5;g/m3) of O3, NO, PM10 (particles 10 micrometers or less in diameter) and SO2 were determined in each geographical area participating in this study.
&#xA0;According&#xA0; to&#xA0; these&#xA0; mean&#xA0; levels, three&#xA0; levels of&#xA0; exposure&#xA0; to&#xA0; each&#xA0; pollutant&#xA0; were considered: level 1 (percentiles 0-25); level 2 (percentiles 26-74); level 3 (percentiles 75-100). Exposure to O3&#xA0; was associated with increased prevalence of rashes (exposure level 2, Odds Ratio (OR): 1.22, 95% Confidence Interval (95%CI): 1.02-1.45; level 3 OR:&#xA0; 1.33, 95%CI:1.10-1.61) and diagnosed AE (level 2, OR: 1.27, 95%CI: 1.17-1.39; level 3 OR: 1.27, 95%CI:1.15-1.41). An association was found between the level of NO and a drop in the prevalence of diagnosed AE (exposure level 2, OR: 0.88, 95%CI: 0.81-0.95; level 3 OR: 0.85, 95%CI:0.74-0.97). There was also an association between the highest exposure level to PM10 and a reduced prevalence of rashes (level 3 OR: 0.42, 95%CI: 0.22-0.81) and diagnosed AE (level 3OR: 0.53, 95%CI: 0.38-0.75).
Future studies into exposure to&#xA0; O3&#xA0;&#xA0; and its relationship with allergic diseases may be conducted in order to prevent this association.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/509</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/509/529</pdf_url>
  </Article>
</Articles>
